Sinsin Pharmaceutical Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sinsin Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 4 470 KRW -3.46% Market Closed

Market Cap: ₩67.8B

S	Sinsin Pharmaceutical Co Ltd KOSDAQ:002800	KR
B	Bodycote PLC OTC:BYPLF	UK
N	National Bank of Greece SA F:NAGF	GR

Profitability Summary

Sinsin Pharmaceutical Co Ltd's profitability score is 54/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

39%

Sustainable 3Y Average Gross Margin

35%

Gross Margin is Increasing

32% > 39%

Healthy Operating Margin

12%

Low 3Y Average Operating Margin

Operating Margin is Increasing

6% > 12%

Healthy Net Margin

11%

Low 3Y Average Net Margin

Net Margin is Increasing

5% > 11%

Healthy Free Cash Flow Margin

10%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

View All

Hide

Collapse

54 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.